Monday, 17 December 2012

AstraZeneca starts mid-stage TB drug trial in South Africa

LONDON (Reuters) - A new experimental drug that may fight drug-resistant strains of the lung disease tuberculosis is being tested in South Africa, where the first patient has been enrolled into a mid-stage clinical trial. (Source: Reuters: Health)

Source: http://www.medworm.com/index.php?rid=6826132&cid=u_0_26_f&fid=23271&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Freuters%2FhealthNews%2F%7E3%2F2j2abAHTSEw%2Fus-astrazeneca-tb-idUSBRE8BA0C420121211

phlebotomy training in michigan local phlebotomy classes phlebotomy training michigan

No comments:

Post a Comment